Literature DB >> 29948609

Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment.

Jennifer R Havens1, Sharon L Walsh2, P Todd Korthuis3, David A Fiellin4,5.   

Abstract

PURPOSE OF REVIEW: To describe the epidemiology of opioid-use disorder in the rural United States (U.S.) as it pertains to HIV and hepatitis C transmission and treatment resources. RECENT
FINDINGS: Heroin and fentanyl analogs have surpassed prescription opioids in their availability in rural opioid markets adding to HIV and hepatitis C (HCV) and overdose risks. Only 18% of rural individuals live in towns with inpatient services which are of limited quality and utility. Opioid treatment programs that provide methadone are not located in rural areas and only 3% of the primary care providers have the ability to prescribe buprenorphine. National models and resources have been established but lack implementation in rural areas leading to ongoing HIV and HCV transmission and overdose. Addressing the adverse impact of opioids in the rural U.S. will require a concerted effort to implement effective treatments according to national standards.

Entities:  

Keywords:  HIV; Hepatitis C; Opioid treatment; Opioid treatment programs

Mesh:

Year:  2018        PMID: 29948609      PMCID: PMC6260984          DOI: 10.1007/s11904-018-0402-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  73 in total

1.  Adolescent OxyContin Abuse.

Authors:  Debra A Katz; Lon R Hays
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-02       Impact factor: 8.829

Review 2.  Major increases in opioid analgesic abuse in the United States: concerns and strategies.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2005-07-14       Impact factor: 4.492

3.  Abuse of prescription drugs and the risk of addiction.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2006-03-23       Impact factor: 4.492

4.  Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

Authors:  David A Fiellin; Michael V Pantalon; Marek C Chawarski; Brent A Moore; Lynn E Sullivan; Patrick G O'Connor; Richard S Schottenfeld
Journal:  N Engl J Med       Date:  2006-07-27       Impact factor: 91.245

5.  Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users.

Authors:  Jennifer R Havens; Robert Walker; Carl G Leukefeld
Journal:  Drug Alcohol Depend       Date:  2006-09-07       Impact factor: 4.492

6.  Treatment of heroin dependence with buprenorphine in primary care.

Authors:  David A Fiellin; Michael V Pantalon; Juliana P Pakes; Patrick G O'Connor; Marek Chawarski; Richard S Schottenfeld
Journal:  Am J Drug Alcohol Abuse       Date:  2002       Impact factor: 3.829

7.  A trial of integrated buprenorphine/naloxone and HIV clinical care.

Authors:  Lynn E Sullivan; Declan Barry; Brent A Moore; Marek C Chawarski; Jeanette M Tetrault; Michael V Pantalon; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  Clin Infect Dis       Date:  2006-12-15       Impact factor: 9.079

8.  Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years.

Authors:  David A Fiellin; Brent A Moore; Lynn E Sullivan; William C Becker; Michael V Pantalon; Marek C Chawarski; Declan T Barry; Patrick G O'Connor; Richard S Schottenfeld
Journal:  Am J Addict       Date:  2008 Mar-Apr

9.  Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.

Authors:  Lynn E Sullivan; Brent A Moore; Marek C Chawarski; Michael V Pantalon; Declan Barry; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  J Subst Abuse Treat       Date:  2007-10-15

10.  Treating homeless opioid dependent patients with buprenorphine in an office-based setting.

Authors:  Daniel P Alford; Colleen T LaBelle; Jessica M Richardson; James J O'Connell; Carole A Hohl; Debbie M Cheng; Jeffrey H Samet
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

View more
  8 in total

1.  Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.

Authors:  Gerald Cochran; Julie Bruneau; Nicholas Cox; Adam J Gordon
Journal:  Subst Abus       Date:  2020       Impact factor: 3.716

2.  Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.

Authors:  Kirsten E Smith; Martha D Tillson; Michele Staton; Erin M Winston
Journal:  Drug Alcohol Depend       Date:  2020-01-09       Impact factor: 4.492

3.  Within-subject evaluation of interim buprenorphine treatment during waitlist delays.

Authors:  Tatum N Oleskowicz; Taylor A Ochalek; Kelly R Peck; Gary J Badger; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2021-01-20       Impact factor: 4.492

4.  Rural Emergency Medical Service Providers Perceptions on the Causes of and Solutions to the Opioid Crisis: A Qualitative Assessment.

Authors:  Heather Blue; Ashley Dahly; Susan Chhen; Julie Lee; Adam Shadiow; Anna G Van Deelen; Laura C Palombi
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

5.  Improving Sexual Health in U.S. Rural Communities: Reducing the Impact of Stigma.

Authors:  Jo A Valentine; Lyana F Delgado; Laura T Haderxhanaj; Matthew Hogben
Journal:  AIDS Behav       Date:  2021-08-26

6.  A Vulnerability Assessment for a Future HIV Outbreak Associated With Injection Drug Use in Illinois, 2017-2018.

Authors:  Cara Jane Bergo; Jennifer R Epstein; Stacey Hoferka; Marynia Aniela Kolak; Mai T Pho
Journal:  Front Sociol       Date:  2021-05-19

7.  Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region.

Authors:  Jacqueline E Sherbuk; Terry Kemp Knick; Chelsea Canan; Patrice Ross; Bailey Helbert; Eleanor Sue Cantrell; Charlene Joie Cantrell; Rachel Stallings; Nicole Barron; Diana Jordan; Kathleen A McManus; Rebecca Dillingham
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

8.  Patterns and Characteristics of Methamphetamine Use Among Adults - United States, 2015-2018.

Authors:  Christopher M Jones; Wilson M Compton; Desiree Mustaquim
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-27       Impact factor: 17.586

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.